Dysgerminoma
Showing 1 - 9 of 9
Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma Trial in United States (Durvalumab, Tremelimumab)
Active, not recruiting
- Germ Cell Tumor
- +5 more
-
Basking Ridge, New Jersey
- +6 more
May 2, 2022
Protein P16 Expression in Ovarian Germ Cell Tumors.
Completed
- Ovarian Neoplasms
- +2 more
- p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)
- Ki67 antibody (DAKO) for malignant cases only
-
Assiut, EgyptAssiut University
Aug 12, 2021
Brain and CNS Tumors, Extragonadal Germ Cell Tumor, Ovarian Cancer Trial in Los Angeles, New York (pegfilgrastim, cisplatin,
Completed
- Brain and Central Nervous System Tumors
- +4 more
- pegfilgrastim
- +3 more
-
Los Angeles, California
- +1 more
Oct 23, 2017
Extragonadal Germ Cell Tumor, Ovarian Cancer, Teratoma Trial in New York (sunitinib malate)
Completed
- Extragonadal Germ Cell Tumor
- +3 more
- sunitinib malate
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Sep 24, 2015
Bladder Cancer, Brain and CNS Tumors, Breast Cancer Trial in San Francisco (lapatinib, paclitaxel)
Completed
- Bladder Cancer
- +8 more
-
San Francisco, CaliforniaUCSF Helen Diller Family Comprehensive Cancer Center
Jul 1, 2014
Ovarian Dysgerminoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor Trial in Chicago (drug,
Terminated
- Ovarian Dysgerminoma
- +7 more
- imatinib mesylate
- +2 more
-
Chicago, IllinoisCancer and Leukemia Group B
Jan 15, 2013
Dysgerminoma Trial in Tuebingen (Darbepoetin alfa)
Completed
- Dysgerminoma
- Darbepoetin alfa
-
Tuebingen, GermanyMedical Center II, University of Tuebingen
Feb 13, 2009